BCL2 and COVID-19: We can speculate that in the context of COVID-19-associated endocrine resistance, elevated Bcl2 expression can help cells evade the apoptotic signals that would typically result from hormone therapy, thus contributing to resistance. It is clear that COVID-19 can disrupt various hormonal pathways through inflammatory responses and direct viral effects on endocrine organs, even creating local memory (1, 55).